Live
- INS Kuthar makes maiden visit to Gopalpur Port
- PM praises city-based NGO for promoting libraries
- Odisha police rescue ‘trafficked’ Bangla girl
- iPhone 16 Plus Now at Rs. 2,000 Discount on Amazon – Get It Today
- How Technology is Shaping Global Connectivity and Enhancing Security
- Dy CM directs officials to collect all critical info on caste census
- Naga Chaitanya Opens Up About His Wedding Plans with Sobhita Dhulipala
- ‘NC24’ First Look Poster: Naga Chaitanya’s Next Promises Thrills and Mythology
- Rumors Heat Up as Vijay and Rashmika Enjoy a Cozy Meal Together
- 67th annual day celebrations held at IRISET
ICMR invites institutions to study plasma therapy
The Indian Council of Medical research has sought letters of intent from institutions with necessary equipment and infrastructure to participate in a clinical trial to study safety and efficacy of therapeutic plasma exchange in COVID-19 patients, subsequent to necessary approvals and clearances.
New Delhi : The Indian Council of Medical research has sought letters of intent from institutions with necessary equipment and infrastructure to participate in a clinical trial to study safety and efficacy of therapeutic plasma exchange in COVID-19 patients, subsequent to necessary approvals and clearances.
The apex medical research body's invite was uploaded on the ICMR website on Sunday.
The project is named "Multi-center, Phase II, Open Label, Randomized Controlled Study of Therapeutic Plasma Exchange in COVID-19".
The Therapeutic Plasma Exchange (TPE) is an experimental procedure for critically ill COVID-19 patients which, the ICMR said, it does not recommend as a treatment option outside of clinical trials.
The primary objective of the study is to assess the efficacy of TPE in improving the clinical status of COVID-19 patients and to evaluate the safety of treatment with anti SARS-CoV-2 plasma in patients with COVID-19.
The study will include hospitalised COVID-19 patients who are critically ill, fulfil the inclusion and exclusion criteria, and are admitted for care at COVID-19 management facilities in India.
